EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Salen‐Type Copper(II) Complexes: Synthesis, Characterization, Computational Studies, Molecular Docking, Anticancer Potential, and Pharmacokinetic Prediction

Abdellatif A Helaly iD, Bandar A Babgi iD, Yoji Kobayashi iD, Rohit K Rai iD, Ehab M M Ali iD, Abdulaziz A Kalantan iD, Walid M I Hassan iD, Mostafa A Hussien iD, Muhammad M I Ismail iD

ChemistryOpen · 2025-09 · 14 (9)

DOI: 10.1002/open.202500061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistryOpen, online erschienen am 01.07.2025. Verfasst von Abdellatif A Helaly und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, King Abdulaziz University (KAU), Jeddah, 21589, Saudi Arabia. Hauptthemen laut MEDLINE: Copper, Antineoplastic Agents, Coordination Complexes. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transition metal complexes are considered a significant treatment for cancer diseases because of their efficacy toward cancer cells. However, most of these compounds have limited potential toward cancer cells due to their organic backbone structure. Here, the synthesis and anticancer screening of three different ligand structures of salen copper(II) complexes are reported: [Cu II (salophen)(H 2 O) 2 ] ( 1 ), [Cu II (salen)(H 2 O) 2 ] ( 2 ), and [Cu II (etho‐salen)(H 2 O) 2 ] ( 3 ). Using density functional theory‐optimized structures, docking active site interactions are evaluated to predict the activity of salen‐type ligands and their copper(II) complexes against cyclin‐dependent kinase 5 (Cdk5 ) and aromatase cytochrome (P450) proteins. The molecular docking study reveals that among all studied ligands and complexes, [Cu II (salen)(H 2 O) 2 ] ( 2 ) has the best docking score value, S = −8.79 and −7.73, with the lowest root mean square deviation (RMSD = 1.02 and 1.09) against proteins Cdk5 and P450, respectively. Anticancer activity against MCF‐7 and HCT‐116 cell lines reveals that [Cu II (salen)(H 2 O) 2 ] ( 2 ) shows favorable behavior with IC 50 values of 212.5 and 98.9 μ m , respectively. Its parent ligand 2 shows lower potency, with IC 50 values of 404.7 μ m in MCF‐7 and 305.2 μ m in HCT‐116. Notably, copper(II) complexes display reduced toxicity rather than cisplatin toward normal HFF‐1 fibroblasts, indicating a more favorable therapeutic window.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperAntineoplastic AgentsCoordination ComplexesHumansMolecular Docking SimulationDensity Functional TheoryDrug Screening Assays, AntitumorCyclin-Dependent Kinase 5Cell Line, TumorLigandsCell ProliferationEthylenediamines

Stichwörter der Autor:innen

ADMET predictionDFTSchiff basebiological activitiescopper complexescytotoxicitysalen‐type ligands

Substanzen

CopperAntineoplastic AgentsCoordination Complexesdisalicylaldehyde ethylenediamineCyclin-Dependent Kinase 5LigandsEthylenediamines

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, King Abdulaziz University (KAU), Jeddah, 21589, Saudi Arabia.
  • Department of Chemistry, Faculty of Science, Damietta University, Damietta, 34517, Egypt.
  • Center of Renewable Energy and Storage Technologies (CREST), Chemistry Program, Division of Physical Sciences and Engineering, King Abdullah University of Science and Technology (KAUST), Thuwal, 23955-6900, Saudi Arabia.
  • Department of Biochemistry, Faculty of Science, King Abdulaziz University (KAU), Jeddah, 21589, Saudi Arabia.
  • Department of Chemistry, Faculty of Science, Tanta University, Tanta, 31527, Egypt.
  • Department of Chemistry, Faculty of Science, Port Said University, Port Said, 42521, Egypt.

ORCID-Profile: Abdellatif A Helaly, Bandar A Babgi, Yoji Kobayashi, Rohit K Rai, Ehab M M Ali, Abdulaziz A Kalantan, Walid M I Hassan, Mostafa A Hussien, Muhammad M I Ismail

Zitieren

APA

Helaly, A. A., Babgi, B. A., Kobayashi, Y., Rai, R. K., Ali, E. M. M., Kalantan, A. A., Hassan, W. M. I., Hussien, M. A., & Ismail, M. M. I. (2025). Salen‐Type Copper(II) Complexes: Synthesis, Characterization, Computational Studies, Molecular Docking, Anticancer Potential, and Pharmacokinetic Prediction. ChemistryOpen, 14(9). https://doi.org/10.1002/open.202500061

Vancouver

Helaly AA, Babgi BA, Kobayashi Y, Rai RK, Ali EMM, Kalantan AA, et al. Salen‐Type Copper(II) Complexes: Synthesis, Characterization, Computational Studies, Molecular Docking, Anticancer Potential, and Pharmacokinetic Prediction. ChemistryOpen. 2025;14(9). doi:10.1002/open.202500061

BibTeX
@article{Helaly2025,
  author = {Helaly, Abdellatif A and Babgi, Bandar A and Kobayashi, Yoji and Rai, Rohit K and Ali, Ehab M M and Kalantan, Abdulaziz A and Hassan, Walid M I and Hussien, Mostafa A and Ismail, Muhammad M I},
  title = {Salen‐Type Copper(II) Complexes: Synthesis, Characterization, Computational Studies, Molecular Docking, Anticancer Potential, and Pharmacokinetic Prediction},
  journal = {ChemistryOpen},
  year = {2025},
  volume = {14},
  number = {9},
  doi = {10.1002/open.202500061}
}
Kostenlos starten →